Investor Relations | シークス株式会社｜SIIX Corporation.

JAPANESE

INVESTOR RELATIONS

Investor Relations

IR NEWS

LEARN MORE

Aug. 23, 2024

IR NEWS

Presentation Material of Consolidated Financial Results of 1H, FY2024
Aug. 09, 2024

IR NEWS

Announcement of establishment of a sales subsidiary in India
Aug. 09, 2024

IR NEWS

Consolidated 2nd quarter Financial Results for the Fiscal Year Ended December 31, 2024
May. 13, 2024

IR NEWS

Consolidated 1st quarter Financial Results for the Fiscal Year Ended December 31, 2024
May. 13, 2024

IR NEWS

Presentation Material of Consolidated Financial Results of Q1, FY2024
Mar. 22, 2024

IR NEWS

Presentation Material of Business Briefing on CDMO business for bio-antibody drugs
Mar. 08, 2024

IR NEWS

Announcement of Acquisition of a new share of Renzoku Biologics Inc., which engaged in the CDMO business (contract manufacturing and development of bio-antibody medicines), through a third-party allotment and making them SIIX’s subsidiary.
Mar. 01, 2024

IR NEWS

NOTICE OF THE 32ND ANNUAL GENERAL SHAREHOLDER’S MEETING
Feb. 20, 2024

IR NEWS

Mid-term Management Plan for 2024-2026
Feb. 14, 2024

IR NEWS

Consolidated Financial Results for the Fiscal Year Ended December 31, 2023
Feb. 14, 2024

IR NEWS

Presentation Material of Consolidated Financial Results of FY2023
Nov. 13, 2023

IR NEWS

Presentation Material of Consolidated Financial Results of Q3, FY2023
Nov. 13, 2023

IR NEWS

Consolidated 3rd Quarter Financial Results for the Fiscal Year Ended December 31, 2023
Oct. 06, 2023

IR NEWS

Integrated Report 2023
Aug. 21, 2023

IR NEWS

Presentation Material of Consolidated Financial Results of 1H, FY2023
Aug. 10, 2023

IR NEWS

Consolidated 2nd Quarter Financial Results for the Fiscal Year Ended December 31, 2023
May. 12, 2023

IR NEWS

Consolidated 1st quarter Financial Results for the Fiscal Year Ended December 31, 2023
May. 12, 2023

IR NEWS

Presentation Material of Consolidated Financial Results of Q1, FY2023
Mar. 02, 2023

IR NEWS

NOTICE OF THE 31ST ANNUAL GENERAL SHAREHOLDER’S MEETING
Feb. 20, 2023

IR NEWS

Presentation Material of Consolidated Financial Results of FY2022
Feb. 14, 2023

IR NEWS

Consolidated Financial Results for the Fiscal Year Ended December 31, 2022
Nov. 14, 2022

IR NEWS

Presentation Material of Consolidated Financial Results of Q3, FY2022
Nov. 14, 2022

IR NEWS

Consolidated 3rd Quarter Financial Results for the Fiscal Year Ended December 31, 2022
Sep. 27, 2022

IR NEWS

Integrated Report 2022
Aug. 19, 2022

IR NEWS

Presentation Material of Consolidated Financial Results of Q2, FY2022
Aug. 10, 2022

IR NEWS

Consolidated 2nd Quarter Financial Results for the Fiscal Year Ended December 31, 2022
May. 13, 2022

IR NEWS

Presentation Material of Consolidated Financial Results of Q1, FY2022
May. 13, 2022

IR NEWS

Consolidated 1st quarter Financial Results for the Fiscal Year Ended December 31, 2022
Mar. 02, 2022

IR NEWS

Notice of The 30th Annual General Shareholder’s Meeting
Feb. 21, 2022

IR NEWS

Consolidated Financial Results of FY2021
Feb. 16, 2022

IR NEWS

Announcement of Construction of New Building of Thai SIIX Co., Ltd.
Feb. 16, 2022

IR NEWS

Announcement of acquisition of land for factory expansion of SIIX EMS MEXICO, S. de R.L de C.V.
Feb. 14, 2022

IR NEWS

Consolidated Financial Results for the Fiscal Year Ended December 31, 2021
Jan. 26, 2022

IR NEWS

Announcement of Notice of Merger between Consolidated Subsidiaries and Change in Specified Subsidiaries

Share Price Information IR Library Calendar of Events Disclosure Policy

IR Library

Download the latest IR materials

Financial Results Midterm Business Plan Materials for Financial Results Briefing Integrated Report

Financial Results

Materials for Financial Results Briefing

Integrated Report

株式情報

Stock Information

LEARN MORE

株式情報

Financial Indices

LEARN MORE

CONTACT US

We use cookies to improve your experience and our services. We also share information about your use of our website with our analytics partners. You can change your cookies settings, please see our Cookie Policy. Otherwise, if you agree to our use of cookies, please continue to use our website.